Novonesis A/S

NSIS B

DK0060336014

Specialty Chemicals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 16/07/2024 pm IST			5-day change	1st Jan Change
425.6 ^DKK	-0.86%		-0.65%	+14.69%

18/06	Transcript : Novozymes A/S - Analyst/Investor Day
18/06	European shares advance ahead of inflation data, more c.bank speakers	RE

Novozymes A/S : Nyt aktietilbagekøbsprogram og finansiel påvirkning fra The BioAg Alliance

January 08, 2014 at 10:20 pm IST

MarketScreener.com By

Under henvisning til Selskabsmeddelelse nr. 28 af dags dato, i hvilken Novozymes offentliggør indgåelsen af The BioAg Alliance med Monsanto, annoncerer et nyt aktietilbagekøbsprogram til en samlet værdi af op til 2 mia. kr.

10. december 2013

Page Content

Latest news about Novonesis A/S

Transcript : Novozymes A/S - Analyst/Investor Day	18/06
European shares advance ahead of inflation data, more c.bank speakers	18/06	RE
NOVONESIS : Key segments outperform in average Q1 24 showing	10/05
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	03/05
Novonesis Provides Sales Guidance for the Year 2024	03/05	CI
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	30/04	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	08/04	CI
China to speed up 'new productive forces', vice president says	26/03	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	21/03	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	21/03
Novonensis expects 2024 adjusted EBITDA margin of 35%	21/03	RE
Novonesis Provides Earnings Guidance for the Year 2024	21/03	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	18/03	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	18/03	CI
FMC Partners With Novonesis in Canada for Biosolution Products	12/03	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	07/03	CI
Novozymes A/S Announces Board Appointments	04/03	CI
Transcript : Novozymes A/S - Shareholder/Analyst Call	04/03
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	12/02	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	08/02
Novozymes, Chr. Hansen Complete Merger Settlement	02/02	MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024	01/02
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	29/01	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	29/01	CI

Chart Novonesis A/S

Duration

Period

More charts

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).

Sector

Specialty Chemicals

Calendar

28/08/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 10:02 pm IST

More Strategies

Ratings for Novonesis A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

429.3 DKK

Average target price

455.6 DKK

Spread / Average Target

+6.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
NOVONESIS A/S	+14.69%	2.92TCr
CATHAY BIOTECH INC.	-25.23%	340.64Cr
BORREGAARD ASA	+10.85%	176.41Cr
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-22.23%	55Cr
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-32.95%	36Cr
BIO-ON S.P.A.	-81.65%	22Cr
CHEMCON SPECIALITY CHEMICALS LIMITED	-10.04%	12Cr

Industrial Biotechnology Chemicals

Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Novozymes A/S : Nyt aktietilbagekøbsprogram og finansiel påvirkning fra The BioAg Alliance

EPS Revisions